2-amino-delta(2)-thiazoline-4-carboxylic acid: RN given refers to parent cpd
2-amino-Delta(2)-thiazoline-4-carboxylic acid : A 1,3-thiazole that is 4,5-dihydro-1,3-thiazole which is substituted at positions 2 and 4 by an amino and a carboxy group, respectively.
ID Source | ID |
---|---|
PubMed CID | 16526 |
CHEBI ID | 64777 |
SCHEMBL ID | 272903 |
MeSH ID | M0065139 |
Synonym |
---|
STL300750 |
nsc25069 |
2150-55-2 |
nsc-25069 |
4-thiazolecarboxylic acid, 2-amino-4,5-dihydro- |
einecs 218-433-0 |
nsc 25069 |
2-amino-2-thiazoline-4-carboxylic acid |
2-amino-delta(2)-thiazoline-4-carboxylic acid |
2-amino-4,5-dihydrothiazole-4-carboxylic acid |
2-amino-4-carboxythiazoline |
2-thiazoline-4-carboxylic acid, 2-amino- |
2-amino-4-thiazoline-4-carboxylic acid |
2-amino-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
AC-076 |
AKOS005145103 |
2-amino-4-thiazolinic acid |
FT-0662084 |
FT-0662085 |
AKOS007930201 |
2-amino-4,5-dihydro-thiazole-4-carboxylic acid |
48431vn59g , |
unii-48431vn59g |
CHEBI:64777 |
l-2-aminothiazoline-4-carboxylic acid |
dl-2-amino-2-thiazolin-4-carboxylic acid |
rac 2-aminothiazoline-4-carboxylic acid |
dl-2-aminothiazoline-4-carboxylic acid |
2-iminothiazolidine-4-carboxylic acid |
2-amino-4,5-dihydro-4-thiazolecarboxylic acid |
2-aminothiazoline-4-carboxylic acid |
dl-2-amino-2-thiazoline-4-carboxylic acid |
FT-0634073 |
SCHEMBL272903 |
(sr)-2-amino-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
mfcd00010067 |
VHPXSBIFWDAFMB-UHFFFAOYSA-N |
2-amino-4,5-dihydro-1,3-thiazole-4-carboxylic acid # |
2-amino-4-carboxythiazole, 4,5-dihydro- |
dl-2-amino-thiazoline-4-carboxylic acid |
W-107546 |
dl-2-amino-.delta.2-thiazoline-4-carboxylic acid |
DTXSID9024510 |
J-010496 |
2-azanyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
Q27133419 |
AS-20115 |
CS-0044002 |
4-thiazolecarboxylicacid,2-amino-4,5-dihydro- |
2-amino-4,5-dihydrothiazole-4-carboxylicacid |
4-thiazolecarboxylicacid,2-amino-4,5-dihydro-,(4s)-(9ci) |
Class | Description |
---|---|
1,3-thiazoles | |
sulfur-containing amino acid | |
amino acid zwitterion | The zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (3.85) | 18.7374 |
1990's | 1 (3.85) | 18.2507 |
2000's | 7 (26.92) | 29.6817 |
2010's | 14 (53.85) | 24.3611 |
2020's | 3 (11.54) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.06) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (7.69%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 24 (92.31%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |